Literature DB >> 19815820

Progenitor cells from the explanted heart generate immunocompatible myocardium within the transplanted donor heart.

David A D'Alessandro1, Jan Kajstura, Toru Hosoda, Alessandro Gatti, Ricardo Bello, Federico Mosna, Silvana Bardelli, Hanqiao Zheng, Domenico D'Amario, M Elena Padin-Iruegas, Adriana Bastos Carvalho, Marcello Rota, Michael O Zembala, David Stern, Ornella Rimoldi, Konrad Urbanek, Robert E Michler, Annarosa Leri, Piero Anversa.   

Abstract

RATIONALE: Chronic rejection, accelerated coronary atherosclerosis, myocardial infarction, and ischemic heart failure determine the unfavorable evolution of the transplanted heart in humans.
OBJECTIVE: Here we tested whether the pathological manifestations of the transplanted heart can be corrected partly by a strategy that implements the use of cardiac progenitor cells from the recipient to repopulate the donor heart with immunocompatible cardiomyocytes and coronary vessels. METHODS AND
RESULTS: A large number of cardiomyocytes and coronary vessels were created in a rather short period of time from the delivery, engraftment, and differentiation of cardiac progenitor cells from the recipient. A proportion of newly formed cardiomyocytes acquired adult characteristics and was integrated structurally and functionally within the transplant. Similarly, the regenerated arteries, arterioles, and capillaries were operative and contributed to the oxygenation of the chimeric myocardium. Attenuation in the extent of acute damage by repopulating cardiomyocytes and vessels decreased significantly the magnitude of myocardial scarring preserving partly the integrity of the donor heart.
CONCLUSIONS: Our data suggest that tissue regeneration by differentiation of recipient cardiac progenitor cells restored a significant portion of the rejected donor myocardium. Ultimately, immunosuppressive therapy may be only partially required improving quality of life and lifespan of patients with cardiac transplantation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19815820      PMCID: PMC2801080          DOI: 10.1161/CIRCRESAHA.109.207266

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  29 in total

Review 1.  Chronic rejection.

Authors:  P Libby; J S Pober
Journal:  Immunity       Date:  2001-04       Impact factor: 31.745

Review 2.  Cell migration, chimerism, and graft acceptance.

Authors:  T E Starzl; A J Demetris; N Murase; S Ildstad; C Ricordi; M Trucco
Journal:  Lancet       Date:  1992-06-27       Impact factor: 79.321

3.  Adult cardiac stem cells are multipotent and support myocardial regeneration.

Authors:  Antonio P Beltrami; Laura Barlucchi; Daniele Torella; Mathue Baker; Federica Limana; Stefano Chimenti; Hideko Kasahara; Marcello Rota; Ezio Musso; Konrad Urbanek; Annarosa Leri; Jan Kajstura; Bernardo Nadal-Ginard; Piero Anversa
Journal:  Cell       Date:  2003-09-19       Impact factor: 41.582

Review 4.  Nuclear reprogramming: a key to stem cell function in regenerative medicine.

Authors:  Jason Pomerantz; Helen M Blau
Journal:  Nat Cell Biol       Date:  2004-09       Impact factor: 28.824

5.  Cardiac-allograft vasculopathy.

Authors:  Robin K Avery
Journal:  N Engl J Med       Date:  2003-08-28       Impact factor: 91.245

6.  Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells.

Authors:  K A Jackson; S M Majka; H Wang; J Pocius; C J Hartley; M W Majesky; M L Entman; L H Michael; K K Hirschi; M A Goodell
Journal:  J Clin Invest       Date:  2001-06       Impact factor: 14.808

7.  Cardiac stem cells delivered intravascularly traverse the vessel barrier, regenerate infarcted myocardium, and improve cardiac function.

Authors:  Buddhadeb Dawn; Adam B Stein; Konrad Urbanek; Marcello Rota; Brian Whang; Raffaella Rastaldo; Daniele Torella; Xian-Liang Tang; Arash Rezazadeh; Jan Kajstura; Annarosa Leri; Greg Hunt; Jai Varma; Sumanth D Prabhu; Piero Anversa; Roberto Bolli
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-25       Impact factor: 11.205

8.  Chimerism of the transplanted heart.

Authors:  Federico Quaini; Konrad Urbanek; Antonio P Beltrami; Nicoletta Finato; Carlo A Beltrami; Bernardo Nadal-Ginard; Jan Kajstura; Annarosa Leri; Piero Anversa
Journal:  N Engl J Med       Date:  2002-01-03       Impact factor: 91.245

9.  Expression of VEGF and angiopoietins-1 and -2 during ischemia-induced coronary angiogenesis.

Authors:  Toshiro Matsunaga; David C Warltier; John Tessmer; Dorothee Weihrauch; Michael Simons; William M Chilian
Journal:  Am J Physiol Heart Circ Physiol       Date:  2003-03-20       Impact factor: 4.733

10.  Telomere length in subpopulations of human hematopoietic cells.

Authors:  Jessica A G Van Ziffle; Gabriela M Baerlocher; Peter M Lansdorp
Journal:  Stem Cells       Date:  2003       Impact factor: 6.277

View more
  16 in total

1.  Stem cell update: highlights from the 2010 Lugano Stem Cell Meeting.

Authors:  Silvana Bardelli; Giuseppe Astori; Daniel Sürder; Tiziano Tallone; Andre Terzic; Gianni Soldati; Tiziano Moccetti
Journal:  J Cardiovasc Transl Res       Date:  2010-10-30       Impact factor: 4.132

2.  Current and future status of stem cell therapy in heart failure.

Authors:  David A D'Alessandro; Robert E Michler
Journal:  Curr Treat Options Cardiovasc Med       Date:  2010-12

3.  Cardiomyogenesis in the developing heart is regulated by c-kit-positive cardiac stem cells.

Authors:  João Ferreira-Martins; Barbara Ogórek; Donato Cappetta; Alex Matsuda; Sergio Signore; Domenico D'Amario; James Kostyla; Elisabeth Steadman; Noriko Ide-Iwata; Fumihiro Sanada; Grazia Iaffaldano; Sergio Ottolenghi; Toru Hosoda; Annarosa Leri; Jan Kajstura; Piero Anversa; Marcello Rota
Journal:  Circ Res       Date:  2012-01-24       Impact factor: 17.367

Review 4.  Stem cell therapy for heart failure.

Authors:  Robert E Michler
Journal:  Methodist Debakey Cardiovasc J       Date:  2013 Oct-Dec

5.  Surgical options for the management of ischemic cardiomyopathy.

Authors:  Robert Michler
Journal:  Curr Treat Options Cardiovasc Med       Date:  2013-10

6.  Bone marrow mesenchymal stem cells stimulate cardiac stem cell proliferation and differentiation.

Authors:  Konstantinos E Hatzistergos; Henry Quevedo; Behzad N Oskouei; Qinghua Hu; Gary S Feigenbaum; Irene S Margitich; Ramesh Mazhari; Andrew J Boyle; Juan P Zambrano; Jose E Rodriguez; Raul Dulce; Pradip M Pattany; David Valdes; Concepcion Revilla; Alan W Heldman; Ian McNiece; Joshua M Hare
Journal:  Circ Res       Date:  2010-07-29       Impact factor: 17.367

7.  Differentiation induction of mouse cardiac stem cells into sinus node-like cells by co-culturing with sinus node.

Authors:  Yi-Bing Fang; Xuan Liu; Jing Wen; Xiao-Jun Tang; Feng-Xu Yu; Ming-Bin Deng; Chang-Xue Wu; Bin Liao
Journal:  Int J Clin Exp Pathol       Date:  2014-04-15

8.  Effects of age and heart failure on human cardiac stem cell function.

Authors:  Daniela Cesselli; Antonio P Beltrami; Federica D'Aurizio; Patrizia Marcon; Natascha Bergamin; Barbara Toffoletto; Maura Pandolfi; Elisa Puppato; Laura Marino; Sergio Signore; Ugolino Livi; Roberto Verardo; Silvano Piazza; Luigi Marchionni; Claudia Fiorini; Claudio Schneider; Toru Hosoda; Marcello Rota; Jan Kajstura; Piero Anversa; Carlo A Beltrami; Annarosa Leri
Journal:  Am J Pathol       Date:  2011-05-19       Impact factor: 4.307

9.  Adult mouse epicardium modulates myocardial injury by secreting paracrine factors.

Authors:  Bin Zhou; Leah B Honor; Huamei He; Qing Ma; Jin-Hee Oh; Catherine Butterfield; Ruei-Zeng Lin; Juan M Melero-Martin; Elena Dolmatova; Heather S Duffy; Alexander von Gise; Pingzhu Zhou; Yong Wu Hu; Gang Wang; Bing Zhang; Lianchun Wang; Jennifer L Hall; Marsha A Moses; Francis X McGowan; William T Pu
Journal:  J Clin Invest       Date:  2011-04-18       Impact factor: 14.808

10.  Dipeptidyl Peptidase-4 Inhibitor Decreases Allograft Vasculopathy Via Regulating the Functions of Endothelial Progenitor Cells in Normoglycemic Rats.

Authors:  Feng-Yen Lin; Chun-Min Shih; Chun-Yao Huang; Yi-Tin Tsai; Shih-Hurng Loh; Chi-Yuan Li; Cheng-Yen Lin; Yi-Wen Lin; Chien-Sung Tsai
Journal:  Cardiovasc Drugs Ther       Date:  2021-12       Impact factor: 3.727

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.